In conversation with... Emmy Boerrigter
from Listen to The Lancet Oncology Hosted by The Lancet
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 11 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on July 30, 2024.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.